Analyst Research
Tetra Bio-Pharma (OTC: TBPMF): Could This $0.20 stock targeting the $70+ billion pain management market be worth $10.00+ in the next 18 months?
Tetra Bio-Pharma (OTC: TBPMF) (TSX: TBP) Current Price (8/3/21) $0.20 Upside Potential Target: $10.00 Next 18 months. Tetra Bio-Pharma (OTC: TBPMF), (TSX: TBP) has a robust clinical pipeline that targets markets valued at more […]